Gemcitabine: all 1,575 studies that test it
Page 15 of 16. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.
- Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic CancerCompletedNCT00064207Phase 2/3
- 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung CancerCompletedNCT00064064Phase 2
- 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerCompletedNCT00064051Phase 2
- Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic CancerCompletedNCT00063947Phase 1
- Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00062270Phase 1/2
- Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal MesotheliomaCompletedNCT00061477Phase 2
- Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.CompletedNCT00061464Phase 2
- Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical TrialCompletedNCT00061451Phase 2
- Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal CancerCompletedNCT00061308Phase 2
- A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related CachexiaCompletedNCT00060502Phase 2
- Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or LymphomaTerminatedNCT00060112Phase 1
- Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerCompletedNCT00059865Phase 1/2
- Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a TaxaneCompletedNCT00059852Phase 2
- S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) CancerCompletedNCT00058318Phase 2
- Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic CancerCompletedNCT00058201Phase 3
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00058149Phase 3
- S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical CancerWithdrawnNCT00057928Phase 3
- Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryCompletedNCT00057798Phase 2
- Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or CarboplatinStatus unknownNCT00055965Phase 3
- S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumCompletedNCT00055835Phase 2
- Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00055757Phase 2
- Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal CancerTerminatedNCT00055432Phase 2
- A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic CancerCompletedNCT00055250Phase 2
- Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder CancerStatus unknownNCT00054626Phase 3
- Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWithdrawnNCT00054392Phase 3
- Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid TumorsCompletedNCT00054288Phase 1
- Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054197Phase 3
- Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00053209Phase 2
- Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00052689Phase 2
- Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00052338Phase 1
- Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian CancerTerminatedNCT00051584Phase 2
- Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid TumorsTerminatedNCT00049608Phase 1
- Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT00049348Phase 2
- Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerCompletedNCT00047307Phase 1
- Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00047047Phase 1
- BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00043095Phase 1
- Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney CancerCompletedNCT00042965Phase 2
- A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.CompletedNCT00042679Phase 2
- Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00041314Phase 2
- Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder CancerCompletedNCT00041106Phase 2
- Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone SurgeryStatus unknownNCT00039546Phase 3
- UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerCompletedNCT00039403Phase 1
- A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.CompletedNCT00035035Phase 3
- A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00034593Phase 2
- A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.CompletedNCT00034489Phase 2
- Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung CancerCompletedNCT00033553Phase 2
- Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid TumorsCompletedNCT00033241Phase 1
- Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00032175Phase 3
- Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerCompletedNCT00031954Phase 2
- Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic CancerTerminatedNCT00031837Phase 3
- Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the UterusCompletedNCT00031629Phase 2
- Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00030732Phase 3
- S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00030433Phase 2
- Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00028834Phase 2
- Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder UrotheliumCompletedNCT00028756Phase 3
- Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast CancerStatus unknownNCT00027989Phase 2
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic CancerCompletedNCT00026403Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00026130Phase 2
- Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT00026104Phase 2
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic CancerCompletedNCT00025168Phase 2
- Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic CancerCompletedNCT00024427Phase 3
- Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00023972Phase 3
- Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00022646Phase 2
- Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract CancerCompletedNCT00022191Phase 3
- Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerStatus unknownNCT00022009Phase 2/3
- Carboplatin and Gemcitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00021346Phase 1
- SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver CancerWithdrawnNCT00020774Phase 2
- Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic CancerStatus unknownNCT00020644Phase 1
- Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the PancreasCompletedNCT00020345Phase 2
- Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasCompletedNCT00019513Phase 1
- Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and NeckCompletedNCT00017498Phase 2
- Gemcitabine and Epirubicin in Treating Patients With Malignant MesotheliomaCompletedNCT00017186Phase 2
- Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00016367Phase 2
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1
- Gemcitabine in Treating Patients With Recurrent or Refractory Bladder CancerWithdrawnNCT00014287Phase 1
- Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the UrotheliumCompletedNCT00014274Phase 2/3
- Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous TreatmentCompletedNCT00014209Phase 2
- S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the EsophagusCompletedNCT00012363Phase 2
- Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the PancreasCompletedNCT00010166Phase 2
- Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile DuctStatus unknownNCT00010088Phase 2
- Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerCompletedNCT00009893Phase 2
- Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00008125Phase 1
- Gemcitabine in Treating Patients With Advanced Colorectal CancerCompletedNCT00007943Phase 2
- Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid TumorsCompletedNCT00007917Phase 1
- Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the CervixTerminatedNCT00006482Phase 2
- Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the PancreasCompletedNCT00006467Phase 2
- Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous LeukemiaCompletedNCT00006462Phase 2
- Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast CancerCompletedNCT00006459Phase 3
- Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous ChemotherapyCompletedNCT00006453Phase 3
- Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00006372Phase 1
- SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00006351Phase 2
- Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNCT00006224Phase 2
- Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder CancerStatus unknownNCT00006118Phase 2
- Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00006117Phase 2
- Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00006116Phase 2
- Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder CancerCompletedNCT00006105Phase 2
- ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT00006048Phase 3
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00006029Phase 1/2
- Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based ChemotherapyCompletedNCT00006028Phase 2
- Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver CancerCompletedNCT00006010Phase 2